SALT LAKE CITY, Jan. 28 /PRNewswire/ -- Ashok C. Khandkar, Ph.D., Chief Science and Technology Officer of Amedica Corporation, a spinal and orthopaedic implant company headquartered in Salt Lake City, has been honored with the 23rd Annual Governor's Medal for Science and Technology, presented by the Utah State Advisory Council on Science and Technology.
A founder of Amedica, Khandkar received the honor for pioneering the development and application of silicon nitride ceramic medical devices for spine and orthopaedic implant patients. Amedica is the only U.S. spinal and orthopaedic technology company to receive FDA and European Community approval for this innovative and disruptive technology.
"I'm extremely honored to receive the Governor's Medal," said Dr. Khandkar. "This achievement reinforces the value of the work that Amedica is accomplishing in bringing effective products to the orthopaedics industry."
"The Amedica team is indeed pleased that Dr. Khandkar has been recognized by the state of Utah and the Governor for his significant contributions at Amedica and within the orthopaedic implant industry," said Ben Shappley, Chief Executive Officer and President of Amedica. "This accomplishment is a testament to his hard work and dedication to developing innovative solutions for neuro and orthopaedic patients worldwide."
Since 1987, the Governor's Medal for Science and Technology Awards program has honored individuals and companies in Utah who have provided distinguished service to the state in the areas of science and technology. The awards were presented at a ceremony on January 5th at Discovery Gateway in Salt Lake City.
Amedica Corporation is ISO 13485 certified, and its products are FDA and CE approved. Amedica Corporation is an emerging orthopaedic implant company focused on using its silicon nitride ceramic technologies to develop and commercialize a broad range of innovative, unique spine and total joint implants for the growing orthopaedic device market. It has brought to market various spinal implant products, while products under development include reconstructive hip and knee implants that may represent a new standard of care in total joint implants based on superior performance, safety and efficacy.
SOURCE Amedica Corporation